{"name":"Poolbeg Pharma plc","slug":"poolbeg-pharma-plc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNMTNWbUx4S3RHUWxPTTVSeUlXWXZRcU4xcTN3V2FpeWkwTDlld3dEVmVpQUxHZkFjZkg3bV9wUURVbFhEMVlxbVduLTlWNUJJejBjRlh2Q3AtcDBIYlp0X1JOcTVRaFFnazJJYUhGZWVKMjdsYktPUXhfb0pEYXNrMFFtNG1lZzlZaHc?oc=5","date":"2026-04-03","type":"patent","source":"Yahoo! Finance Canada","summary":"Poolbeg Pharma on patent grant and plans - ICYMI - Yahoo! Finance Canada","headline":"Poolbeg Pharma on patent grant and plans - ICYMI - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOc0laVk9KQTNIS1plelh4cVVvNkxXbXJNa0xhT01haW9DRTJoOVp4V2tPVW5fc2UyZ2k4aEhYenBuU0ZMc1lSSXh3OHVjN080TE5fOGNMNFZGcnJZZmYtdWFLbkdXZndSS0RiN0dYZnEwVFlXNlpKUTlqa0VRcDNCOTVqU1N1WFNFYzRPQjJMMnppd29RUjBZc2RHQ2Y5Ny1NakhISUZleDlTSmpIdGo0TzVQTG1zTE9hM1hnOVFwS3hGUjlCZ1RQWGtLdExrMUl1TWtrVHhrQzRoZi1yRWQwTw?oc=5","date":"2026-04-02","type":"pipeline","source":"Proactive financial news","summary":"Accesso, Light Science Technologies, Poolbeg Pharma, Digitalbox, RC Fornax, Gaming Realms - Proactive financial news","headline":"Accesso, Light Science Technologies, Poolbeg Pharma, Digitalbox, RC Fornax, Gaming Realms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPSWsxYVRya2hESF9kZVhCcWJ2WmlYUTVhMkJuSWh1dUlOLTdSZEVqZUpfVW9RbjhiTGxXVm5YQUNUWXd2a3ZqVTdrMnZGUGhZa041X2FHZmdEYVoxU0tFZWdKckhmR3lXNzBQa1RfczhOM0ZQekZxZmcyM3Rhb0s1Ymt6dDRwVEljX2NoWXNTMWtaTFdDZ29QaG9BQTRUQmVic2laSE9CdVFOZzluczQ4N293UGs0Wk9OZ0tnbEJJdV9aVlJmTWdjQUo5TF9JYXI0Rkl4dk1hS0dOMDZRQXhxRTFmVU0?oc=5","date":"2026-04-02","type":"pipeline","source":"Proactive financial news","summary":"Accesso, Light Science Technologies, Poolbeg Pharma, Digitalbox, RC Fornax, Gaming Realms - Proactive financial news","headline":"Accesso, Light Science Technologies, Poolbeg Pharma, Digitalbox, RC Fornax, Gaming Realms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxQcUtFX2RZak5KeDlNaHBFUjl0Wm1QdE1qZ1NfazZneFJHUHZqZ1lnd1hTSFctRHlxN29QZGhzekRjM0ZSUkJrY2VJOXFaek9icWhrZGtpNG1OUXlPWm9sZ1ZiR1VrY0VLek9zaGpYV0dWSXpOOEpXUEdmZnFVV2N6YmJoR1FJc1M1dWNWVjFMUzlYcllScWxfTm9XQlZtZjFnYTdyalpZV21aemZZLXN3blBueVZRcWFXV25HamVjVF9hNEEwRTRKbl9Lc0FnM2J1OG5MN2lERDM4eDZnbEExTGw0LUlQdzZ6aVBiYjFobkU?oc=5","date":"2026-03-31","type":"deal","source":"Proactive financial news","summary":"Poolbeg Pharma CEO says POLB-001 patent win strengthens Big Pharma partnership potential - Proactive financial news","headline":"Poolbeg Pharma CEO says POLB-001 patent win strengthens Big Pharma partnership potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOZ3lDZENhNmEwVmFqMS1RVlZVRG9LUXlNajkxd3daVUE0NUd0WkMyX0E5NEEzajUwYnY5NWcxdnpKMTNXUjhUMW8tUWJtLThlVXhFWk5LX2ppMnczQzlGNExlalUzWVFud3JYVzN1UW9iV09wbmxrUW15NXZISDR0bkVldHVtZk9QTVlSRVNiWnBKcDBrcEdnb2trSF9BaXJBZjdBVm5RbnNocGFhMTdwYzRBeFgtR3J6T1kzRmpnRWV2dHhYa1UzcDhZUFpObTFfcmYxejlMWVBWc2h2MXdld2o4eW5oN3BQOGc?oc=5","date":"2026-03-31","type":"deal","source":"Proactive financial news","summary":"Poolbeg Pharma CEO says POLB-001 patent win strengthens Big Pharma partnership potential - Proactive financial news","headline":"Poolbeg Pharma CEO says POLB-001 patent win strengthens Big Pharma partnership potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNb3ROM2RIUlVZa05YeU5hZEJ3c0xyTmJFa3Y5Tzhhd1Zla2hJZ1ZSY3ViZ0psbjh6OEFVQzQ1YVZOc2xLdHhVRWpLbTVQeWJXZ0xLN2xmVUp4X1dqUGprUGVJbnhGTmVQS1c1dnFQeFY4U2ZlWi1uLVhsZTEyMnBlMVdnQi03X1FaZ1hpQ1VVeTdITWY0VUJfakxtOTZmUnZpeU4xWkRYMVhkVEtJUkw0bmpTU0drRTYxX05Qd2RKZW9WdTJrUkhXVGp1U3JqOUJSTjZaY0M3UGpnTU1VMFNGd25CaU00YXJYYzgwNTBDQzJGWnZ1VXppdg?oc=5","date":"2026-03-31","type":"patent","source":"Proactive Investors","summary":"Poolbeg Pharma shares rise 10% as Australian patent grant bolsters POLB 001 commercial appeal - Proactive Investors","headline":"Poolbeg Pharma shares rise 10% as Australian patent grant bolsters POLB 001 commercial appeal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNcmU3WmIwTnNIRzdkdHRFeVpkVXc2TlIweXdPZkgweWNTUl9HYU9ueE5NUDFDcUUzMmtLdlNBaUpMM2UzbVZldTNPcnJGOGowQy1lcnUxblRoV2hKY2Nxajl4OXdZSXplZnluNHFNUi1HU1c3czBHdTQtckFRZmcyRGw4UDAwM2poWVhwMWtRRmszUTluSDZuLUhqR1pmcWVk?oc=5","date":"2026-03-31","type":"pipeline","source":"Share Talk","summary":"Poolbeg Pharma (AIM: POLB) Significant milestone for Poolbeg’s IP portfolio - Share Talk","headline":"Poolbeg Pharma (AIM: POLB) Significant milestone for Poolbeg’s IP portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQbW83OEh6UWVyS1JoWE1mcjlJeDl5TFRXOHFSN29iWGt4Q0I2NTdJUzJrdTZKMl8wYk5MclNqQnVpR0V5OUI5NzcwLWQ1NzNfekMxWDQ2QXdnTTRDeEdVLTI0WWJEX0ZTYUNyRnluSXlZQzFBbkQ1bVZ0T1BHWlJSZWlPdWN1amUxWUNoeHZrVERlUEVVRE5PNmk2Y3hxbHNPdmdCellFNlI2TTNuQmZUd05XLUNNcU1XaTdxTElPUGNEUnY1ajhoY29nR1hwV2NYay1ETW5meXUwZ2dJa0J2S2pGZkFDdEczM09kWVF1V0U1RVha?oc=5","date":"2026-03-31","type":"patent","source":"Proactive financial news","summary":"Poolbeg Pharma secures first national patent for cancer immunotherapy side-effect treatment - Proactive financial news","headline":"Poolbeg Pharma secures first national patent for cancer immunotherapy side-effect treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPS3kzQXM1Wl82STA3UVFlZ3lQeGxDcVNKNGE4S1RBaE1SNXRYTHZfWkMyY09OakVUTlFheHpXSWtFclpaTnNwbTctLWg5bllYUnhmaHBEVmtWSW1Za0VlOW9HRThpajV1eVNCX0hFMnMzamlFdUowYjFvMllVLXM2enRFWXZneEkwUmk4Nmx3c0pBcFp2cVZMRldyWk9RelMtZHZCYnFzSWc5QXNkbmFpYW5wbWNLZ3g2T19reWxVYlRCU0wweFJuWC0wSktTcVBWMEV0U0YxU0c1VkRtSlFtYXFOalFWZ2VtRWFKYUlMWHNIS1V3MGM1bw?oc=5","date":"2026-03-31","type":"patent","source":"Proactive financial news","summary":"Poolbeg Pharma secures first national patent for cancer immunotherapy side-effect treatment - Proactive financial news","headline":"Poolbeg Pharma secures first national patent for cancer immunotherapy side-effect treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQMkpLS3NocXU5X0lKQU5XeldENXBDZ3JBdkJGdDJXTG9Xd0szVTIyZGZlU2RwTTd5bUNQT0tsWkhEZW5jWmd5VEdMQ01yY0k4MmtvSS1qemhoNUM5dU9Ha29MUWNNMEQyc19XeDVlN2pjSDVDSEVwWEFRaEx1UXJUWkhwb0F0c3lQS3U3MEtXbzN1UExWX1RoaG16a083SFY3b0tPMWFOc3ZtM085WWZv?oc=5","date":"2026-03-31","type":"patent","source":"London South East","summary":"IN BRIEF: Poolbeg Pharma celebrates Australian patent \"milestone\" - London South East","headline":"IN BRIEF: Poolbeg Pharma celebrates Australian patent \"milestone\"","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNd0h4SUh3bXRHZXJjUllkM1kzdWM0eUowZzB0czNkaFBMYVdsTzlBMlJjbXFPanFtem9fNTY5dmo4WFZ4SjIzal9PUjN4bG5BV2JQWlZwZ1hiWTltUWhQN3RLZUVrZEV1SHZmN1FxLUtuMWtvYXZNc1UyVjZoVVhpbzdYU0tObVBYaE1wdm9Eek5aU0FkdC11Mm15Smx0elFBNmo1dGhWdVBlQQ?oc=5","date":"2026-03-30","type":"patent","source":"Yahoo Finance","summary":"Poolbeg Pharma secures first national patent for cancer immunotherapy side-effect treatment - Yahoo Finance","headline":"Poolbeg Pharma secures first national patent for cancer immunotherapy side-effect treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPbXlfMDNoNUlzUC11ajYtMGpSRmI0RW1jX0RIWTZEcm5lc3VYNDlIdEp4Z3dyeVh2cFBkZ1R2eGhiNFh3VVQyVGtGTC1sbUdzOGp4YWFWTXhOQ3hsRjdjaERyMjdyclBtTGpraXFncUZreHFLNzRXdzZaQTcxc281TEJSaFl4T2lxN0gtWDBielBLRmZQa0M0N1Z2X2VQTGs?oc=5","date":"2025-12-18","type":"pipeline","source":"Share Talk","summary":"Poolbeg Pharma (AIM: POLB) Letter to Shareholders – 2025 a year of progress - Share Talk","headline":"Poolbeg Pharma (AIM: POLB) Letter to Shareholders – 2025 a year of progress","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}